by ActuatedAdmin | Dec 6, 2022 | Press Release
BELLEFONTE, PA – Actuated Medical, Inc. has been awarded a Phase I and Phase II Exploratory/Developmental Phased grant from the National Institutes of Health (NIH) under the National Heart, Lung, and Blood Institute (NHLBI) Catalyze Program. The project focuses on... by ActuatedAdmin | Nov 29, 2022 | Press Release
BELLEFONTE, PA – Actuated Medical, Inc. has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Institutes of Health – National Institute of Neurological Disorders and Stroke (NIH-NINDS) entitled “Development of a miniaturized... by ActuatedAdmin | Nov 22, 2022 | Press Release
BELLEFONTE, PA, November 22, 2022 – Actuated Medical, Inc. has been awarded a continuation Small Business Innovative Research (SBIR) grant from the National Institutes of Health – National Institutes of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) entitled... by ActuatedAdmin | Nov 18, 2022 | Press Release
BELLEFONTE, PA – Actuated Medical Inc. has been awarded a Fast-track Small Business Innovative Research (SBIR) grant from the National Institutes of Health-National Institute of Mental Health (NIH-NIMH) entitled “Development of an Acoustic Implant Protection (AIP)... by ActuatedAdmin | Nov 9, 2022 | Press Release
BELLEFONTE, PA – Actuated Medical will attend Neuroscience 2022, the annual meeting of SfN. Roger Bagwell, Ph.D. (Director R&D & Co-Founder) and Kyle Gheres, Ph.D. (Neural Device Leader & Senior Scientist) will be representing Actuated Medical and the... by ActuatedAdmin | Nov 2, 2022 | Press Release
BELLEFONTE, PA – Actuated Medical Inc. has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA) entitled “Oscillated Insertion Tool for Minimally...
Recent Comments